Search Results - "D’Offizi, Giampiero"
-
1
No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
Published in Frontiers in pharmacology (22-04-2021)“…No specific treatment has been approved for COVID-19. Lopinavir/ritonavir (LPV/r) and hydroxychloroquine (HCQ) have been used with poor results, and a trial…”
Get full text
Journal Article -
2
Alpps for Primary and Secondary Liver Tumors
Published in International journal of surgery (London, England) (01-06-2016)“…Abstract Introduction To report our experience on associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in patients with liver…”
Get full text
Journal Article -
3
A 15-year experience of two hundred and twenty five consecutive right hepatectomies
Published in Digestive and liver disease (01-01-2017)“…Abstract Background In case of liver tumor, surgical resection is the therapeutic gold standard to increase patient survival. Among liver resections, right…”
Get full text
Journal Article -
4
-
5
-
6
-
7
Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options
Published in Mediterranean journal of hematology and infectious diseases (01-03-2021)“…Coronavirus disease 2019 (COVID-19) is mainly a respiratory tract disease and acute respiratory failure with diffuse microvascular pulmonary thrombosis are…”
Get full text
Journal Article -
8
Cystic lymphoepithelial lesions of the parotid gland in HIV-1 infection
Published in AIDS patient care and STDs (01-03-2000)“…The benign cystic lymphoepithelial lesion (BLL) of the parotid gland is a rare disorder affecting HIV-1-infected patients. Here we describe the clinical and…”
Get more information
Journal Article -
9
Transarterial Radioembolization Can Downstage Intermediate and Advanced Hepatocellular Carcinoma to Liver Transplantation
Published in Transplantation (17-09-2024)“…Transarterial radioembolization (TARE) is an effective treatment to control tumor growth and improve survival in hepatocellular carcinoma (HCC). The role of…”
Get full text
Journal Article -
10
Vδ1T Lymphocytes Expressing a Th1 Phenotype Are the Major γδ T Cell Subset Infiltrating the Liver of HCV-infected Persons
Published in Molecular medicine (Cambridge, Mass.) (01-01-2001)Get full text
Journal Article -
11
Elevated P-Selectin in Severe Covid-19: Considerations for therapeutic options: P-Selectine and COVID-19
Published in Mediterranean journal of hematology and infectious diseases (26-02-2021)“…BACKGROUND: Coronavirus disease 2019 (COVID-19) is mainly a respiratory tract disease and acute respiratory failure with diffuse microvascular pulmonary…”
Get full text
Journal Article -
12
Mutations in HIV-1 Reverse Transcriptase Potentially Associated with Hypersusceptibility to Nonnucleoside Reverse-Transcriptase Inhibitors: Effect on Response to Efavirenz-Based Therapy in an Urban Observational Cohort
Published in The Journal of infectious diseases (01-05-2004)“…Background. Hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors (NNRTIs) was described in association with reverse-transcriptase (RT)…”
Get full text
Journal Article -
13
THU451 - HCV DAA treatment failure is associated to hepatocellular carcinioma presence
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
14
HCV DAA treatment failure is associated to hepatocellular carcinioma presence
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
15
Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients?
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
16
Third dose of SARS-COV2 mRNA-vaccine in liver transplant recipients: can it bridge the response gap?
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
17
-
18
-
19
-
20